Lilly pauses COVID-19 antibody trial after factory hits trouble with FDA
Facebook Bans Ads Questioning Safety Of COVID-19 Vaccines
Record number of health firms feature in UK top 100 private tech list
Nestlé Completes Tender Offer For 84% Stake In Aimmune Therapeutics
Operation Warp Speed Boss Projects Covid-19 Vaccine EUA by Thanksgiving
Abbott wins U.S. emergency use authorization for new Covid-19 antibody test
3 COVID-19 Antibody Stocks That Are Leading the Race
Spotlight on COVID-19 antibody therapies after Trump’s recovery
Pfizer, BioNTech Initiate Rolling Canada Submission For Covid-19 Vaccine
"Big Tech Has Become A Tool Of Totalitarian Fascism" - Google Has 'Memory-Holed' The Great Barrington Declaration
Global Trial Launches to Test Remdesivir with hIVIG in Covid-19
London Mayor Says Another Lockdown "Inevitbale" As Global COVID-19 Cases Near Record Daily Highs: Live Updates
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
GenMark Pops 13% On Very Strong 3Q, FDA Emergency Clearance
Regeneron joins Lilly in seeking emergency OK for COVID-19 antibody
Is Gilead Stock a Buy Right Now? This Is What You Need to Know
Regeneron: Emergency Use Authorization for REGN-COV2 Is Imminent, Says Analyst
BioNTech, Rentschler Partner For Covid-19 Vaccine Manufacturing
Blocking immune system pathway may stop COVID-19 infection, prevent severe organ damage
Global Markets Rise On Continued "Stimulus Optimism"
Gilead Inks EU Supply Deal For 500,000 Remdesivir Doses
Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy
Ocular Lifted By Strong 3Q Prelim Net Product Sales
Integra Jumps 6% On Raised 3Q Sales Outlook
Company of the Year 2020: Bristol-Myers Squibb — Patience Rewarded
Bayer 2020: End in sight
Gilead 2020: HIV … and COVID?
Amgen 2020: 40-Year-Old Pioneer
AstraZeneca 2020: Driven by Covid-19
AbbVie 2020: Beyond Humira